dr tyna moore tirzepatide + Metabolic Health: What the Latest Study Really Shows Using GLP-1s: Benefits, Beyond Obesity

You can reach out with questions or concerns through the portal

Although their mechanisms differ, both medications are designed to support sustainable weight loss by helping reduce calorie intake and improve metabolic balance

Section 7: Expert Opinions and Guidelines Section 7: Expert Opinions and Guidelines The integration of semaglutide into treatment protocols, particularly for patients undergoing hormone replacement therapy (HRT), has prompted a need for expert guidance and standardized clinical guidelines

Most patients remain on semaglutide for 612 months to reach their target range, followed by a gradual, structured taper into the maintenance phase

State paid family and medical leave programs: California (CFRA/SDI), New York (NY PFL), New Jersey (NJFLA), Washington (WA PFML), Massachusetts (MAPFML), Oregon (OPFML), Colorado (FAMLI), Connecticut (CTFMLA), and others

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist and is currently the most direct comparator to Mounjaro